Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 26, 2009 - Issue 5
Submit an article Journal homepage
208
Views
8
CrossRef citations to date
0
Altmetric
Articles

THE BENEFIT OF ATG IN IMMUNOSUPPRESSIVE THERAPY OF CHILDREN WITH MODERATE APLASTIC ANEMIA

Shayi Jiang Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD, PhD,
Yaoping Wang Department of Hematology and Ocology, Shanghai Children's Medical Center, Shang Hai, China
, MD,
Wei Shi Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD,
Yuexia Shao Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD,
Xiaohong Qiao Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD,
Jieliang Lin Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD,
Hanqin Kuang Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD &
Xiaotian Xie Department of Pediatric, Tongji Hospital, Tongji University, Shang Hai, China
, MD show all
Pages 313-320 | Accepted 26 Oct 2008, Published online: 13 Aug 2009

REFERENCES

  • Champlin R E, Ho W, Gale R P. Antilymphocyte globulin treatment in patients with aplastic anemia: A prospective randomized trial. N Engl J Med 1983; 308: 113–118
  • Frickhofen N, Heit W, Raghavachar A, et al. Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin. Klin Wochenschr 1986; 64: 1165–1170
  • Rosenfeld S J, Kimball J, Vining D, et al. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85: 3058–3065
  • Maciejewski J P, Sloand E M, Nunez O, et al. Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood 2003; 102: 3584–3586
  • Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood. 1999; 93: 2191–2195
  • Seiji K, Shigeyoshi I, Yoshiyuki K, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000; 96: 2049–2054
  • Monika F, Udo R, Irith B, et al. Immunosuppressive therapy for aplastic anemia in children: A more severe disease predicts better survival. Blood 2005; 106: 2102–2104
  • Khatib Z, Wilimas J, Wang W. Outcome of moderate aplastic anemia in children. Am J Pediatr Hematol Oncol 1994; 16: 80–85
  • Howard S C, Naidu P E, Hu X J, et al. Natural history of moderate aplastic anemia in children. Pediatr Blood Cancer 2004; 43: 545–551
  • Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 1999; 93: 2191–2195
  • Xiaotian X, Yaoping W, Wei S, et al. Immunosuppressive therapy for childhood aplastic anemia. Chin J Pediatr 2001; 39: 484–487
  • Xiaotian X, Yaoping W, Wei S, et al. Effects of combined immunosupressive therapy on severe aplastic anemia and refractory aplastic anemia in children. Chin J Contemp Pediatr 2006; 6: 492–496

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.